Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-008521

Chief Executive Officer gave up 24,683 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-02-06 Shares withheld for taxes −24,683 375,611 D: show line 1 in the form
Loading xslF345X03/doc4.xml…